The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia

Medical Hypotheses

Volumn 64, Issue 1, 2005, Pages 162-169

  Manten, G T R ^a   Van Der Hoek, Ytje Y ^a   Marko Sikkema, J ^a   Voorbij, Hieronymus A M ^a   Hameeteman, Ton M ^a   Visser, Gerard H A ^a   Franx, Arie ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPOPROTEIN A;

ACUTE DISEASE; ANAMNESIS; ARTICLE; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CONCENTRATION (PARAMETERS); DELIVERY; DISEASE SEVERITY; ENDOTHELIUM LESION; FEMALE; GENETICS; GESTATION PERIOD; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK FACTOR;

BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEIN(A); MODELS, BIOLOGICAL; NETHERLANDS; PRE-ECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 7944221213     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.04.026     Document Type: Article

References (38)

1. van Beek E., Peeters L.L.H. Pathogenesis of preeclampsia: a comprehensive model. Obstet. Gynecol. Surv. 53:1998;233-239
2. Roberts J.M., Redman C.W.G. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 341:1993;1447-1451
3. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1989;1200-1204
4. Pijnenborg R., Anthony J., Davey D.A., Rees A., Tiltman A., Vercruysse L., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 98:1991;648-655
5. Stewart D.J., Monge J.C. Hyperlipidemia and endothelial dysfunction. Curr. Opin. Lipidol. 4:1993;319-324
6. Sattar N., Petrie J.R., Jaap A.J. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis. 138:1998;229-235
7. Lorentzen B., Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Sem. Reprod. Endocrin. 16:1998;33-39
8. Sattar N., Bendomir A., Berry C., Shepherd J., Greer I.A., Packard C.J. Lipoprotein subfraction concentrations in pre-eclampsia: pathogenic parallels to atherosclerosis. Obstet. Gynecol. 89:1997;403-408
9. Dahlén G.H. Lp (a) lipoprotein in cardiovascular disease. Atherosclerosis. 108:1994;111-126
10. Utermann G. The mysteries of lipoprotein (a). Science. 246:1989;904-910
11. Berg K. Lp (a) lipoprotein: an overview. Chem. Phys. Lipids. 67/68:1994;9-16
12. van der Hoek, Y.Y., 1995. Lipoprotein (a): structure/function, analysis and metabolism [dissertation] Amsterdam. University of Amsterdam, The Netherlands
13. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature. 300:1987;132-137
14. Pekelharing H.L.M., Kleinveld H.A., Duif P.F.C.C.M., Bouma B.N., van Rijn H.J.M. Effect of lipoprotein (a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator. Thromb. Haemost. 75:1996;497-502
15. Lippi G., Braga V., Adami S., Guidi G. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein (a) levels after bisphosphonates-induced acute phase response. Clin. Chim. Acta. 271:1998;79-87
16. Min W.K., Lee J.O., Huh J.W. Relation between lipoprotein (a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease. Clin. Chem. 43:1997;1891-1895
17. Noma A., Abe A., Maeda S., Seishima M., Makino K., Yano Y., et al. Lp (a): an acute-phase reactant. Chem. Phys. Lipids. 67/68:1994;411-417
18. Liu A.C., Lawn R.M. Vascular interactions of lipoprotein (a). Curr. Opin. Lipidol. 5:1995;269-273
19. Sorensen K.E., Celermajer D.S., Georgakopoulos D., Hatcher G., Betteridge D.J., Deanfield J.E. Impairment of endothelial-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J. Clin. Invest. 93:1994;50-55
20. Redman C.W.G., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180:1999;499-506
21. Meekins J.W., Pijnenborg R., Hanssens M., van Assche A., McFadyen I.R. Immunohistochemical detection of lipoprotein (a) in the wall of placental bed spiral arteries in normal and severe pre-eclamptic pregnancies. Placenta. 15:1994;511-524
22. Wang J., Mimuro S., Lahoud R., Trudinger B., Wang X.L. Elevated levels of lipoprotein (a) in women with preeclampsia. Am. J. Obstet. Gynecol. 178:1998;146-149
23. Bar J., Harell D., Bardin R., Pardo J., Chen R., Hod M., et al. The elevated plasma lipoprotein (a) concentrations in preeclampsia do not precede the development of the disorder. Thromb. Res. 105:2002;19-23
24. Sattar N., Clark P., Greer I.A., Shepherd J., Packard C.J. Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia. Atherosclerosis. 148:2000;407-411
25. 1 are altered in preeclampsia. Clin. Genet. 52:1997;371-376
26. van Pampus M.G., Koopman M.M.W., Wolf H., Büller H.R., Prins M.H., van den Ende A. Lipoprotein (a) concentrations in women with a history of severe preeclampsia;a case control study. Thromb. Haemost. 82:1999;10-13
27. He S., Silveira A., Hamsten A., Blombäck M., Bremme K. Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb. Haemost. 81:1999;538-542
28. Irgens H.U., Reisæter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 323:2001;1213-1217
29. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158:1988;892-898
30. Kamboh M.I., Ferrell R.E., Kottke B.A. Expressed hypervariable polymorphism of apolipoprotein (a). Am. J. Hum. Genet. 49:1991;1063-1074
31. Prins J., Leus F.R., Bouma B.N., van Rijn H.J.M. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene: association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration. Thromb. Haemost. 82:1999;1709-1717
32. Marcovina S.M., Zhang Z.H., Gaur V.P., Albers J.J. Identification of 34 apolipoprotein (a) isoforms: differential expression of apolipoprotein (a) alleles between American blacks and whites. Biochem. Biophys. Res. Commun. 191:1993;1192-1196
33. Marcovina S.M., Albers J.J., Gabel B., Koschinsky M.L., Gaur V.P. Effect of the number of apolipoprotein (a) kringle 4 domains on immunochemical measurements of lipoprotein (a). Clin. Chem. 41:1995;246-255
34. Manten G.T.R., Franx A., van der Hoek Y.Y., Hameeteman T.M., Voorbij H.A.M., Smolders H.C., et al. Changes of plasma lipoprotein (a) during and after normal pregnancy in Caucasians. J. Matern. Fetal. Neonatal. Med. 14:2003;1-5
35. Zechner R., Desoye G., Schweditsch M.O., Pfeiffer K.P., Kostner G.M. Fluctuations of plasma lipoprotein-A concentrations during pregnancy and post partum. Metabolism. 35:1986;333-336
36. Brizzi P., Tonolo G., Esposito F., Puddu L., Dessole S., Maioli M., et al. Lipoprotein metabolism during normal pregnancy. Am. J. Obstet. Gynecol. 181:1999;430-434
37. Sattar N., Greer I.A., Rumley A., Stewart G., Shepherd J., Packard C.J., et al. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy. Thromb. Haemost. 81:1999;71-75
38. Clausen T., Djurovic S., Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. Br. J. Obstet. Gynaecol. 108:2001;1081-1087